CBA, CSL and Macquarie Group on track for $100 shares

Original article by Simon Evans
The Australian Financial Review – Page: 22 : 22-Jan-15

Shares in CSL and the Commonwealth Bank are currently trading at about $A84. While they have recently retreated from 12-months peaks, both stocks could potentially rise to $A100. CSL previously undertook a share split after its stock rose to $A100 in late 2007. Arnhem Investment Management’s George Clapham suggests that in many cases a demerger rather than a share split may generate more value for shareholders. Macquarie Group’s shares are currently trading above $A60, and the stock is also a potential candidate to breach $A100

CORPORATES
CSL LIMITED – ASX CSL, COMMONWEALTH BANK OF AUSTRALIA – ASX CBA, MACQUARIE GROUP LIMITED – ASX MQG, ARNHEM INVESTMENT MANAGEMENT PTY LTD, AMCOR LIMITED – ASX AMC, ORORA LIMITED – ASX ORA, BRAMBLES LIMITED – ASX BXB, RECALL HOLDINGS LIMITED – ASX REC, IRON MOUNTAIN INCORPORATED, ELDERS LIMITED – ASX ELD, BERKSHIRE HATHAWAY INCORPORATED

CSL looks to purify Ebola victim antibodies

Original article by Pia Akerman
The Australian – Page: 21 : 16-Oct-14

John Shine, chair of Australian-listed biotechnology group CSL, addressed its AGM on 15 October 2014. He said the company was in talks with the World Health Organisation on a potential push to create new drugs for the fight against the Ebola virus. However there are no immediate plans for the development of a vaccine, which is at least a year away according to CEO Paul Perreault. Meanwhile CSL has announced a $A950m stock repurchasing scheme, following six previous such moves that were worth $A3.3bn combined

CORPORATES
CSL LIMITED – ASX CSL, WORLD HEALTH ORGANIZATION